National Scholar Award

This award is designed to identify and nurture promising investigators at a junior level, encouraging early career researchers to work towards the more senior Rising Stars Award.

The National Scholar Award is based on National Society affiliation. Among all abstracts accepted for presentation, the highest scoring abstracts per country are chosen.

We consider abstract presenters under 35 years of age.


Awardees 2018

Anh Do, Australia
4211 THE INCREASE OF EFFECTOR MEMORY T-CELLS IN SMALL INTESTINE OF FUNCTIONAL GASTROINTESTINAL DISORDER (FGID) PATIENTS RELATING TO GUT BACTERIA AND SYMPTOM GENERATION

Lisa Mayr, Austria
1989 POLYUNSATURATED FATTY ACIDS INDUCE FERROPTOTIC INFLAMMATION IN THE INTESTINE

Lucas Wauters, Belgium
1062 EFFICACY AND SAFETY OF LANREOTIDE IN POSTOPERATIVE DUMPING SYNDROME: A PHASE III, DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER STUDY

Cintia Kimura, Brazil
4113 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) VERSUS TRANSANAL ENDOSCOPIC MICROSURGERY (TEM) FOR THE TREATMENT OF EARLY RECTAL CANCER: COMPARISON OF LONG TERM OUTCOMES

Jenna Tessolini, Canada
2612 MAINTENANCE LEVELS OF VEDOLIZUMAB DO NOT CORRELATE WITH CLINICAL REMISSION IN IBD PATIENTS

Pu Wang, China
1292 ASSISTANCE OF A REAL-TIME AUTOMATIC COLON POLYP DETECTION SYSTEM INCREASES POLYP AND ADENOMA DETECTION DURING COLONOSCOPY: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY

Viktor Domislović, Croatia
4139 PREVALENCE AND FACTORS ASSOCIATED WITH SEXUAL DYSFUNCTION AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Zuzana Rabekova, Czech Republic
2925 A SINGLE CENTER EXPERIENCE WITH PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR ACHALASIA- TWO-YEAR FOLLOW-UP AND BEYOND

Christian Borup, Denmark
308 A PROSPECTIVE VALIDATION STUDY: 7Α-HYDROXY-4-CHOLESTEN-3-ONE IS SUPERIOR TO FIBROBLAST GROWTH FACTOR-19 STIMULATED WITH A MEAL PLUS CHENODEOXYCHOLIC ACID FOR DIAGNOSING BILE ACID DIARRHOEA

Roberto Oleas, Ecuador
958 FIRST SPANISH VALIDATED TRANSLATION OF A SINGLE HEALTH-RELATED QUALITY OF LIFE SURVEY FOR BROAD USE ACROSS DIFFERENT CHRONIC ESOPHAGEAL DISEASES: A PSYCOMETRIC EVALUATION OF THE NEQOL SURVEY IN AN ECUADORIAN POPULATION

Hagar Elessawy, Egypt
1278 COMPARISON OF THE LEVELS OF CIRCULATING MICRORNA-122 IN HCV-RELATED CIRRHOSIS PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA

Mathurin Fumery, France
1232 POSITIVE HISTOLOGIC MARGINS IS A RISK FACTOR OF RECURRENCE AFTER ILEOCAECAL RESECTION IN CROHN’S DISEASE

Lukas Perkhofer, Germany
522 ACTIONABLE PERTURBATIONS IN THE DNA DAMAGE RESPONSE ESTABLISH SYNERGISTIC THERAPEUTIC ROUTES IN ATM DEFICIENT PANCREATIC CANCER

Adonis Protopapas, Greece
3114 INCREASED ALVEOLAR NITRIC OXIDE CONCENTRATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SIGN OF SUBCLINICAL SMALL AIRWAY INFLAMMATION?

Yuhang Zhou, Hong Kong, China (SAR)
853 FGFR2 SIGNALING CROSSTALKS WITH HIPPO PATHWAY TO DRIVE GASTRIC CARCINOGENESIS

Emese Tóth, Hungary
1627 GENETIC INHIBITION OF CYCLOPHILIN D PROTECTS AGAINST BILE ACID OR ETHANOL AND FATTY ACID INDUCED PANCREATIC DUCTAL EPITHELIAL CELL DAMAGE IN MICE

Ankur Jindal, India
328 EFFICACY AND SAFETY OF TRANSJUGULAR PORTOSYSTEMIC SHUNT IN DIFFICULT-TO-MANAGE HYDROTHORAX IN CIRRHOSIS

Catriona Gallagher, Ireland
811 IBD PATIENTS ARE FOUR TIMES MORE LIKELY TO DEVELOP ALL TYPES OF SKIN CANCER POSSIBLY RELATED TO HIGH RATES OF IMMUNOSUPPRESSION; WITH YOUNG PATIENTS PARTICULARLY AT RISK OF MELANOMA

Dana Ivancovsky-Wajcman, Israel
1532 SERUM SRAGE LEVELS ARE ASSOCIATED WITH LIFESTYLE AND WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Beatrice Foglia, Italy
3444 HYPOXIA-INDUCIBLE FACTOR 2ALPHA IS CRITICAL FOR NASH-RELATED EXPERIMENTAL LIVER CARCINOGENESIS.

Taisuke Obata, Japan
2427 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC TUMORS UNDER THE CONTINUOUS ADMINISTRATION OF ANTICOAGULANTS

Myung Ji Goh, Republic of Korea  
2274 STATIN USE AND THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B

Zane Straume, Latvia
3888 ACUTE UPPER GASTROINTESTINAL BLEEDING IN PATIENTS USING ANTITHROMBOTIC AND NON-STEROIDAL ANTI-INFLAMMATORY THERAPY: CONTRIBUTING FACTORS AND OUTCOMES

Viktorija Basyte - Bacevice, Lithuania
570 TM6SF2 AND MBOAT7 GENE VARIANTS ARE NOT ASSOCIATED WITH THE RISK OF DEVELOPING LIVER FIBROSIS AND CIRRHOSIS IN AN EASTERN EUROPEAN POPULATION

Jorge Luis de León Rendón, Mexico
58 GENETIC POLYMORPHISMS OF INTERFERON GAMMA (IFN-ϒ) IN MEXICAN-MESTIZO PATIENTS WITH ABDOMINAL SEPSIS

Zahra Bouhnoun, Morocco
3010 SHOULD WE ASK FOR AN ILEO-COLONOSCOPY IN ALL PATIENTS WITH SPONDYLOARTHROPATHY OR ONLY IN SYMPTOMATIC PATIENTS?

Nicolien Schepers, The Netherlands
858 EARLY ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY WITH BILIARY SPHINCTEROTOMY OR CONSERVATIVE TREATMENT IN PREDICTED SEVERE ACUTE BILIARY PANCREATITIS (APEC): A MULTICENTER RANDOMIZED CONTROLLED TRIAL

Elisabeth Kjelsvik Steinsvik, Norway
1986 PSYCHOLOGICAL FACTORS IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS: RELATION TO DYSPEPTIC SYMPTOMS AND GASTRIC DYSMOTILITY AS MEASURED WITH ULTRASOUND

Tahir Mehmood, Pakistan
2143 COMPARISON OF INCIDENCE AND SURVIVAL OUTCOMES IN MUCINOUS AND SIGNET-RING CELL COLORECTAL CANCERS WITH CLASSICAL ADENOCARCINOMA: A SEER ANALYSIS

Mark Lester Sy, Philippines
1162 EFFECTIVENESS OF REBAMIPIDE IN THE PREVENTION OF ESOPHAGEAL STRICTURE FORMATION IN ADVANCED CORROSIVE ESOPHAGITIS: A PROSPECTIVE RANDOMIZED CONTROL STUDY

Anna Chaber-Ciopinska, Poland
1250 NARROW BAND IMAGING ENDOSCOPY VERSUS LUGOL CHROMOENDOSCOPY IN EARLY DETECTION OF ESOPHAGEAL CANCER IN PATIENTS WITH HEAD AND NECK CANCERS: RANDOMIZED TRIAL

Luísa Martins Figueiredo, Portugal
2943 RISK FACTORS FOR THE EMERGENCE OF MULTIDRUG-RESISTANT ORGANISMS IN LIVER CIRRHOSIS

Vasile Sandru, Romania
3996 ARE PLASTIC STENTS “EXPANDABLE” IN THE TREATMENT OF BILIARY STRICTURES AFTER ORTHOTOPIC LIVER TRANSPLANTATION?

Maria Markelova, Russian Federation
3861 COMPARISON OF INTESTINAL MICROBIOTA COMPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES DEPENDING ON THE PLACE OF RESIDENCE (URBAN OR RURAL)

Tamara Knezevic Ivanovski, Serbia
89 FECAL CALPROTECTIN MAY BE A SENSITIVE BIOMARKER IN ASSESMENT OF HISTOLOGIC DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS

Jing Liang Ho, Singapore
3543 POST-ERCP PANCREATITIS (PEP): MINIMIZING ROLE OF PANCREATIC DUCT (PD) STENTING WITH NON-INVASIVE COMBINATION THERAPY IN DIFFICULT CASES

Martin Duricek, Slovakia
3483 LARYNGOPHARYNGEAL REFLUX AND COUGH REFLEX SENSITIVITY

Jurij Hanžel, Slovenia
689 INDUCTION AND EARLY MAINTENANCE VEDOLIZUMAB TROUGH LEVELS PREDICT MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE

Liseth Rivero Sánchez, Spain
4018 HIGH DEFINITION WHITE-LIGHT COLONOSCOPY VERSUS CHROMOENDOSCOPY FOR SURVEILLANCE OF LYNCH SYNDROME. A MULTICENTER, RANDOMIZED AND CONTROLLED STUDY (ENDOLYNCH STUDY)

John-Peter Ganda Mall, Sweden
2757 EFFECTS OF DIETARY FIBRES ON INDOMETHACIN-INDUCED INTESTINAL PERMEABILITY IN ELDERLY: A RANDOMISED PLACEBO CONTROLLED PARALLEL CLINICAL TRIAL

Egle Katkeviciute, Switzerland
1944 LOSS OF PTPN2 IN DENDRITIC CELLS RESULTS IN REDUCED TUMOR BURDEN IN THE AOM/DSS COLON TUMOR MOUSE MODEL

Dhanusorn Wanichagool, Thailand
1171 THE EFFICACY OF PENTOXIFYLLINE ON ACUTE PANCREATITIS

Bellil Nawel, Tunisia
3092 PREDICTIVE VALUE OF PAGE-B SCORE IN TUNISIAN PATIENTS WITH CHRONIC HEPATITIS B UNDER ENTECAVIR.

Haluk Tarik Kani, Turkey
3989 DREAM ANXIETY IN INFLAMMATORY BOWEL DISEASE

Lidiia Babenko, Ukraine
3274 COMBINED USE OF LACTOBACILLUS AND BIFIDOBACTERIA PROBIOTIC STRAINS WITH NANOCERIA REDUCE CHOLESTEROL LEVEL IN OBESITY MOUSE MODEL

Sharmila Subramaniam, United Kingdom
2224 BLEEDING DURING ENDOSCOPIC SUBMUCOSAL DISSECTION: A RANDOMISED CONTROLLED TRIAL OF A NOVEL HAEMOSTATIC AGENT

Eszter Hegyi, United States
2282 MISFOLDING CARBOXYPEPTIDASE MUTANT INDUCES CHRONIC PANCREATITIS IN MICE

National Scholar awardees are:

  • Highlighted in the final programme of UEG Week
  • Invited to participate in the Young GI Network activities at UEG Week such as the mentoring programme or the networking event “Let’s meet!”
  • Invited to attend a reception with UEG leadership and other awardees in the Young GI Network Lounge

Scientific Committee, Programme & Faculty Management
Maresa Wiener
________________________________________________________

M +43 699 1997 16 05
T +43 1997 1639
F +43 1997 1639 10 
________________________________________________________

m.wiener@ueg.eu